Product Information
DAPTOMYCIN 500 MG VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $22.6865 per EA under NDC 00143946501. Its NADAC has been published 43 times since Oct 29, 2025.
FDA first approved this application on Jun 15, 2016. Its Orange Book therapeutic-equivalence code is AP.
Strength
500 mg/10mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143946501
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
DAPTOMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA206005FDA Approved
6/15/2016
TE Code
AP
On Market Since
9/30/2025
Pharmacological Classes
Price Statistics
The NADAC for DAPTOMYCIN 500 MG VIAL has been published 43 times since Oct 29, 2025, and over the history we have for it it has risen 12.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.6865 per EA |
|---|---|
| All-time high | $22.6865 (Aug 19, 2026) |
| All-time low | $20.1020 (Oct 29, 2025) |
| 52-week high | $22.6865 |
| 52-week low | $20.1020 |
| Median price | $20.7686 |
| Average price | $20.9419 |
| Largest weekly change | +8.9% (Aug 19, 2026) |
| Weeks tracked | 43 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DAPTOMYCIN 500 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DAPTOMYCIN 500 MG VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $22.6865 per EA (NDC 00143946501), effective Aug 19, 2026.
How has the price of DAPTOMYCIN 500 MG VIAL changed over time?
Over the history we have for it, the NADAC for DAPTOMYCIN 500 MG VIAL has risen 12.9%. It has been tracked across 43 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for DAPTOMYCIN 500 MG VIAL?
Since Oct 29, 2025, the NADAC for DAPTOMYCIN 500 MG VIAL has ranged from a low of $20.1020 (Oct 29, 2025) to a high of $22.6865 (Aug 19, 2026), with a median of $20.7686 per EA.
Are there cheaper alternatives to DAPTOMYCIN 500 MG VIAL?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DAPTOMYCIN 500 MG VIAL, is $20.7686 per EA — about 8% below DAPTOMYCIN 500 MG VIAL.
Who manufactures DAPTOMYCIN 500 MG VIAL?
DAPTOMYCIN 500 MG VIAL (NDC 00143946501) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.